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Abstract The paper presents results of physico-chemical
and biological investigations of a surface-engineered syn-
thetic bone filler. Surface analysis confirms that the ce-
ramic phosphate granules present a collagen nanolayer to
the surrounding environment. Cell cultures tests show that,
in agreement with literature reports, surface-immobilized
collagen molecular cues can stimulate progression along
the osteogenic pathway of undifferentiated human mes-
enchymal cells. Finally, in vivo test in a rabbit model of
critical bone defects shows statistically significant increase
of bone volume and mineral apposition rate between the
biomimetic bone filler and collagen-free control. All to-
gether, obtained data confirm that biomolecular surface
engineering can upgrade the properties of implant device,
by promoting more specific and targeted implant-host cells
interactions.
1 Introduction
To support efficient installation of dental implants after
restoration of alveolar bone loss, or sinus lift surgery, or to
fill periodontal and periimplant bone defects, many dif-
ferent bone substitutes such as autografts, xenografts, al-
lografts and osteoactive agents have been proposed [1–7].
Among them, xenograft and synthetic bone fillers present
the advantage of an unlimited supply of available material
and lack of morbidity by eliminating the donor site.
Xenografts, in particular from bovine source, take a good
share of the market, because the fine microarchitecture and
properties of the original bone tissue, together with a good
record of clinical performances, make them a reliable al-
ternative to autograft [8, 9]. Among synthetic bone fillers,
mostly based on phosphate ceramics, represent the major
and widespread bone reconstructive and replacement tool
employed in the orthopedic field, because they offer the
opportunity of advanced material engineering [10–12].
Structural, chemical and morphological properties (the ra-
tio between different components—mostly hydroxyapatite
and b-tricalcium phosphate-, topography, porosity, Ca/P
ratio, grain size and shape, effect of atomic substitutions)
have been widely investigated [13], in order to maximize
the rate of new bone formation and finely tune the degra-
dation rate obtaining ‘‘biomimetic’’ biocompatible materi-
als that closely mimic the inorganic components of bone
tissue. Nevertheless synthetic bone graft substitutes cur-
rently possess only osteointegrative and osteoconductive
properties.
Surface engineering is another tool offered by material
science to upgrade properties of synthetic bone fillers. In
particular, biomolecular modification of surfaces is an ef-
fective strategy to improve device-tissue interaction, by
presentation of signaling molecules able to direct cell
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behavior and stimulate healing at the device-tissue inter-
face [14–16]. In the field of bone-contacting devices, a
number of papers highlights the merits of surface modifi-
cation by type I collagen in periimplant bone regeneration.
Collagen type I is the most abundant protein in bone, where
it makes up approximately 85 % of the organic portion.
Cellular interactions with collagen have been shown to be
important in the regulation of the osteoblast phenotype.
Collagen controls adhesion of cells of direct relevance to
bone-contacting applications [17], through the amino acid
sequence Arg-Gly-Asp (RGD) that it contains. It plays an
important role in osteoblast cells behaviour, promoting not
only cell adhesion, but also osteoblastic differentiation of
bone marrow cells and controlling a number of aspects of
their progression along the osteogenic pathway [18–20].
RGD interacts with critical biomolecules and growth fac-
tors, providing the cooperative signaling required for
BMPs functioning [21]. It exerts a strong pro-coagulant
(hemostatic) activity and it activates platelets in a unique
way [22]. This aspect is of definite interest on the light of
the role of early blood–implant interactions in bone healing
[23–25]. For the reasons mentioned above, collagen is
commonly used in dental and orthopedic surgery as os-
teogenic and bone filling material, where it provides a more
rapid regeneration of bone defects. Even some xenograft
filler takes advantage of collagen properties, by low tem-
perature processing that keeps collagen within the inor-
ganic bone matrix.
Recently, a new synthetic biomimetic bone filler that
exploits biomolecular surface engineering to deliver di-
rectly to the filler-implant interface the signaling properties
of type I collagen has been developed. Contrary to other
fillers where it is part of the bulk of the material or a major
component of the formulation, in the present case collagen
is just contained as a surface cross-linked nanolayer, whose
thickness is of the order of nanometers, on top of 25 %
hydroxylapatite, 75 % b-tricalciumphospate granules. It is
expected that interfacial interaction between host cell and
the surface nanolayer can stimulate bone regeneration
mechanisms, promoting faster and more consistent bone
formation in the defect. Thus, despite being synthetic in
nature, this new synthetic biomimetic bone filler can play
an active biological role in the healing process, by colla-
gen-host cells communication.
To the authors’ knowledge, the biomolecular surface
engineering applied to synthetic calcium phosphate fillers
represents an innovative approach to upgrade materials
properties that requires in vitro and in vivo preclinical in-
vestigations. Thus the scope of this paper was to investigate
the specific surface chemistry and relevant biological im-
plications of this newly developed synthetic bone filler. To
this end, the surface chemical composition of tested bone
filler was evaluated by techniques that probe different
sampling depths, such as attenuated total reflection infrared
spectroscopy (ATR-IR) and X-ray photoelectron spec-
troscopy (XPS). Human mesenchymal cells cultures on
tested bone filler and relevant control were used to evaluate
in vitro, through RT-PCR, the expression of the gene en-
coding for alkaline phosphatase, the main marker of pro-
gression along the osteogenic pathway. Finally, bone
regeneration in vivo was investigated in a rabbit model of
bone defect.
2 Materials and methods
The following samples were tested:
(1) Synthetic bone filler (SB) based on 25 % hy-
droxylapatite (HA)–75 % b-tricalciumphospate
(b-TCP) granules, 0.3–1 mm size range, bearing a
surface cross-linked nanolayer of collagen form
porcine source
(2) Collagen-free, 25 % hydroxylapatite–75 % b-trical-
ciumphospate control granules (SB-), 0.3–1 mm size
range.
Samples were prepared as follows:
A slurry obtained by thorough mixing of 75 % b-TCP
(Sigma) and 25 % HA (Fuildinova, Portugal) in a 3 %
aqueous solution of guar gum was prepared. Disks, about
4 cm diameter, were dried at 100 C in a oven. Dried disks
were pressed for 10 s at 170 bar using a Mignon EA/SSN
press. Disks were then sintered at 1100 C, with a 1 h
dwelling time and a 1 C/min ramp rate, using a Lenton
ECF 12/4 chamber furnace.
Sintered samples were then mechanically grinded and
the 0.3–1 mm fraction recovered through calibrated ana-
lytical sieves (Retchs). Complete characterization of the
bulk phases of the obtained material is reported elsewhere
(Morra M. et al., submitted manuscripts).
Half of the obtained material was packaged in sterile
vials and coded SB-. The remaining half was subjected to
the collagen coating process. Shortly, granules were placed
in a 0.1 % collagen type I solution (TheraCol, Sewon
Cellontech Co., Ltd., Korea). After overnight incubation at
room temperature the collagen solution was then displaced
by phosphate buffer and samples rinsed with pyrogen-free
MilliQ water. Cross-linking of the adsorbed collagen layer
was obtained by adding water-soluble carbodiimide (EDC)
and N-hidroxysuccinimide (NHS) to the aqueous solution
containing the samples. After 2 h, samples were washed
and dried under a hood (SB). Further to packaging both SB
and SB- were gamma sterilized.
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2.1 Surface analysis investigations
2.1.1 ATR-IR
ATR-IR spectra were obtained using a Nicolet iS10 ATR-
IR spectrometer, produced by Thermo Scientific and
equipped by a diamond crystal. SB and SB- granules were
gently placed on the crystal and kept in place by the
specific crimping tool. The experimental set up involves
acquisition of 32 scans in the range 500–4000 cm-1, both
of sample and background, at a resolution of 4 cm-1 [21].
2.1.2 XPS
XPS analysis was performed with a Perkin Elmer PHI 5400
ESCA system. The instrument is equipped with a Mg an-
ode operating at 10 kV and 200 W. The diameter of the
analyzed spot is approximately 2 mm, the base pressure
10-8 Pa. The angle between the electron analyzer and the
sample surface was 45.
Measurements were performed by pressing SB and SB-
granules, in order to make a complete layer on a double
sided adhesive tape, one side of which was fixed to the
instrument sample holder.
Analysis was performed by acquiring wide range survey
spectra (0–1000 eV binding energy) and detailed high
resolution peaks of relevant elements.
Quantification of elements was accomplished using the
software and sensitivity factors supplied by the
manufacturer.
2.2 Human mesenchymal stem cell (hMSC) culture
hMSC from bone marrow were purchased from Cambrex
Bio Science (Milan, Italy). On arrival, the culture medium
was immediately removed and replaced by new Mes-
enchymal Stem Cell Basal Medium (MSCBM, Cambrex
Bio Science) supplemented with 10 % fetal bovine serum
and L-glutamine, penicillin/streptomycin (all from Cam-
brex Bio Science).
At subconfluence, cells were harvested by adding suf-
ficient volume of Clonetics Trypsin–EDTA (CC-3232,
Milan, Italy) solution to cover the cell layer, and gently
rocking the flask. After blocking Trypsin by serum, cells
were seeded in the experimental wells (described below) at
a density of about 7 9 104 cell/mL, as evaluated by TC10
automated cell counter (Bio Rad, Milan, Italy).
For the experiments a thin layer of SB and SB- (about
0.20 g) was separately spread on the bottom of 24 multi-
well plates (Falcon, Becton&Dickinson, Milan, Italy),
completely masking the underlying plastic substrate. Three
replicate wells were used for each experimental time. Cells
were seeded on wells containing SB or SB- and cultured at
37 C in a humidified incubator equilibrated with 5 %
CO2, in the following culture media:
– Ostegenic medium: the cell culture medium was
supplemented with hMSC differentiation bullet kit
(PT-3002, Cambrex Bio Science), which contains
dexamethasone, ascorbate, L-glutamine, penicillin/
streptomycin, b-glycerophosphate;
– Non differentiating medium: culture medium without
osteogenic differentiation supplement factors.
2.3 RT-PCR
The expression of ALP gene as a cell differentiation
markers was assessed using the real time reverse tran-
scription polymerase chain reaction (qRT-PCR). hMSC
cells were cultured on the described materials and total
RNA was extracted at 3, 7 and 14 days time points using
MagMax Total RNA Isolation Kit (Applied Biosystems,
Milan, Italy) following the manufacturer’s instructions.
RNA quality was assessed by checking the A260/A280
ratio (1.6–2.0). Then total RNA was used as a template for
cDNA synthesis using random hexamers as primer and
multiscribe reverse transcriptase (high capacity cDNA RT
Kit from Applied Biosystems).
cDNA amplification and relative gene quantification
was performed using Taq Man probe and primers from
Applied Biosystems (Hs 01029144_m1, ALP). Real time
PCR was performed in duplicate for all samples and targets
on a Step-One instrument (Applied Biosystems) using the
software Step-One, version 2.1. PCRs were carried out in a
total volume of 20 ll and the amplification was performed
as follows: after an initial denaturation at 95 C for 10 min,
the PCR was run for 40 cycles at 95 C for 15 s and at
60 C for 1 min.
To normalize the content of cDNA samples, the com-
parative threshold (Ct) cycle method, consisting on the
normalization of the number of target gene copies versus
the endogenous reference gene GAPDH, was used. The Ct
is defined as the fractional cycle number at which the
fluorescence generated by cleavage of the probe passes a
fixed threshold baseline when amplification of the PCR
product is first detected. For comparative analysis of gene
expression, data were obtained using the DCt method.
2.3.1 Determination of in vivo histocompatibility
2.3.1.1 Animal model After synthetic bone filler charac-
terization, in vivo evaluations have been performed also
following the international rules UNI EN ISO 10993-6:
2009 ‘‘Biological evaluation of medical devices—tests for
local effects after implantation’’ in order to obtain infor-
mation about material in vivo performance in terms of
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histocompatibility and osteointegrative capabilities. All
surgical care and procedure were performed following the
Italian and European Laws on animal experimentation. The
research protocol was approved by the Ethical Committees
of the Rizzoli Orthopaedic Institute and by the public au-
thorities as provided by Law by Decree 116/92.
Ten male New Zealand rabbits (HARLAN Laboratories
SRL, S.Pietro al Natisone—Udine), 3.06 ± 0.15 kg body
weight, were housed in individual cages and fed with a
standard pellet diet (Mucedola, Settimo Milanese, Milano,
Italia) and water ad libitum used. After a quarantine period
of 10 days, the animals were submitted to surgery for ex-
perimental materials placement in the trabecular bone tis-
sue of femoral condyles. The animals were intramuscular
injected with 44 mg/kg ketamine (Imalgene 1000, Merial
Italia S.p.A, Assago-Milan, Italy) and 3 mg/kg xylazine
(Rompun, Bayer SpA, Milano, Italy) were performed to
induce general anesthesia. During surgery anesthesia was
maintained with O2/air (1/0.4 l/min) mixture and 2–2.5 %
sevorane (Sevorane, ABBOTT Srl, Latina, Italy).
Longitudinal incisions on the lateral surface of femoral
condyles were performed bilaterally and distal femurs ex-
posed. Critical size defects of 6 mm in diameter and 10 mm
in depth were created with a low speed drill, flushing and
cooling with sterile 0.9 % NaCl to remove bone debris.
Subsequently, SB and SB- materials were implanted in left
and right femoral condyles, respectively, and wounds were
sutured in layers. Postoperatively, antibiotics and analgesics
therapies were administered. To monitor the dynamic of
bone ingrowth, the animals received i.m. injections of
oxytetracycline fluorochrome (30 mg/kg b.w., Terramicina
100, Pfizer Italia, Italy) 2 days on, 10 days off and 2 days on,
18 days before the end of experimental time.
Twelve weeks after surgery, animals were sacrificed
with the intravenous administration of 1 ml of Tanax
(Tanax, Hoechst, Frankfurt am Main, Germany) under
general anesthesia as previously reported. Femoral con-
dyles were explanted and during dissection, the presence of
clinical signs of inflammation, haematomas, oedema, or
tissue reactions were macroscopically evaluated; also
lymphatic draining district (popliteal and inguinal lymph
nodes) was taken into consideration.
2.3.1.2 Microtomographical, histological and dynamic
histomorphometric evaluations Microtomographic assess-
mentwas carried out onto femoral condyles samples using the
Skyscan 1172 computed microtomographic system. The
scans were performed with a source voltage of 100 kV, at a
source of 100 lA and using an aluminum filter 0.5 mm. Each
samplewas rotated until 180with a rotation step of 0.4 and a
frame averaging of 4. The pixel size was 13.5 lm. The
reconstructions were performed using NRecon (v1.6.2.0)
software and the resulted jpg images had 2000 9 2000 pixels
with a pixel size of 13.5 lm. For reconstruction the specific
misalignment for each acquisition, a small smoothing and a
beam hardening correction of 20 % were applied.
The reconstructed crossectional images constitute the
whole volume for each sample. Using the CTAn software
(Skyscan, Belgium) the datasets of these images were
elaborated to perform the 3D analysis (directly on the
volume). A cylindrical volume of interest (VOI) corre-
sponding to the surgical defect (6-mm in diameter and
10-mm in height) was considered for each sample. Within
the VOI the following parameters were calculated:
– Volume of the material in the defect (Mat.V/TV, %):
expressed as a ratio between the volume of the material
in the VOI and the total volume of the considered VOI;
– Bone volume density (BV/TV, %): expressed as a ratio
between the volume of newly formed bone measured in
the VOI and the total volume of the considered VOI;
– Ratio between bone tissue surface and measured tissue
volume (BS/BV, mm-1): expressed as a ratio between
the bone tissue surface inside the VOI (BS, mm2) and
the volume of the newly formed bone inside the VOI
(BV, mm3).
After micro-CT scan, femoral condyles were processed
for non-decalcified histology. Bone sample were immedi-
ately fixed in 4 % paraformaldehyde, dehydrated in an
ascending series of ethanol concentrations until the abso-
lute one and finally embedded in a methyl methacrylate
resin solution (Methyl Methacrylate stabilized for synthe-
sis, Merck Schuchardt OHG, Hohenbrunn, Germany). Se-
rial transversal sections were obtained by using rotative
microtome (Leica SP1600, Leica Microsystems Spa, Mi-
lan) with a 40 ± 10 lm thicknesses. The obtained sections
were then ground and polished until 15 ± 5 lm thick-
nesses with Saphir system (Saphir 550, ATM GmbH,
Mammelzen, Germany) and left unstained for dynamic
histomorphometry or stained with Stevenel Blue counter-
stained with Picrofucsin according to Van Gieson method
for qualitative histological evaluations.
To perform dynamic histomorphometric investigations,
semi-automatically light/fluorescence microscope (BX51,
Olympus Optical Co. Europe GmbH, Germany) connected
to an image analyzer system (Qwin, Leica Imaging Sys-
tems Ltd., United Kingdom) was used and different
regions of interest (ROIs) were grabbed at 209
magnification. The following histomorphometric pa-
rameters were evaluated:
– Mineral apposition rate (MAR, lm/day): measured as
the distance between the midpoints of two consecutive
deposited and epifluorescent fronts of fluorochrome
divided by the time between the the labelling period.
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– Bone formation rate (BFR/B.Pm lm2/lm/day): BFR/
B.Pm values were obtained by multiplying the MAR
value by the sum of  single label perimeter (sL.Pm)
and double label (dL.Pm) perimeter as explained by the
following formula:
MAR  ð1=2 sL:Pm=B:Pmþ dL:Pm=B:PmÞ
All stained histological sections were finally digitized
adopting a digital scanner at full resolution (1781 9
1467 pixels).
2.3.1.3 Statistical analysis Statistical analysis was per-
formed using SPSS v.12.1 software (SPSS Inc., Chicago,
Illinois). Data are reported as mean ± standard deviation
(SD) at a significance level of P\ 0.05. After having ver-
ified the normal distribution and the homogeneity of the
variance, Student t test for paired data was used, to assess the
significant differences between the SB and SB- materials.
3 Results
3.1 Surface analysis
ATR-IR spectrum of SB in the range 500–4000 cm-1, is
shown in Fig. 1a. The most important observation from this
spectrum is that only peaks belonging to the inorganic
phase, that is the intense phosphate stretching bands ob-
served at around 1010 and 560 cm-1, were detected. The
phosphate band is reported in more details in Fig. 1b.
Confirming the claimed composition, it contained features
belonging both to hydroxylapatite and b-tricalci-
umphospate (950 and 1140 cm-1) [26]. The main features
of the triply degenerated asymmetric stretching mode (m3)
of the P–O bond of the phospate group is shown in Fig. 1b.
The 1125 cm-1 peak is typical of tricalciumphospate,
while peaks at lower wavenumber bear features both of
tricalciumphospate and hydroxylapatite [27].
In this respect, the SB spectrum was definitely identical
to that of SB- (not shown). No evidence of the presence of
collagen was gathered from this analysis; proteinaceous
compounds should show the typical amide peaks in the
1500–1700 cm-1 range.
The chemical composition of the surface of SB and SB-
granules, as detected by XPS analysis, is reported in
Table 1. Data show a very significant difference between
elemental distributions on the granule surface. SB-, as
expected, contained a high percentage of Ca and P, and no
N. SB, on the other hands, showed a significant amount of
nitrogen, a marked reduction of Ca and P, and an increase
of the carbon content. The overall stoichiometry detected
on SB was consistent with that of collagen and of collagen
coated implants [27]. Further indications were gathered
from the high-resolution C1 s peak of SB (Fig. 2). The
peak showed the typical shoulder at about 288–289 eV,
that is 3.5–4 eV shift from the main C–C, C–H component,
due to C in the amide bond chemical environment.
3.2 hMSC culture
hMSC were cultured on SB- and SB layers, both in os-
teogenic and non-differentiating media. The main hallmark
of progression of undifferentiated hMSC along the os-
teogenic pathway was the increase of ALP expression.
Results of RT-PCR measurement of ALP gene expres-
sion are shown in Fig. 3. Measurements were performed
after 3, 7 and 14 days culturing. Data are reported as fold
expression of ALP gene expression by hMSC cultured on
SB over ALP gene expression by hMSC cultured on SB-.
Considering first data obtained in osteogenic medium, fold
expression is always close to one, meaning that ALP gene
expression is almost identical between cells cultured on
SB- or SB. Interestingly, data obtained in non-differenti-
ating medium show a completely different trend: while fold
expression is close to one after 3 days, induction time, very
significant overexpression of ALP gene is detected after 7
and 14 days for cell cultured on SB.
3.2.1 Determination of in vivo histocompatibility
Anesthesia procedures and postoperative healing period
were uneventful for all animals that fulfilled the predeter-
mined experimental time without complications, except for
an animal that was excluded from ex vivo assessments due
to the occurrence of a microfracture at the implant site in
which the experimental material was implanted (in the
absence of clinical signs). Surgical defects healed without
complications and macroscopically no adverse tissue bone
tissue or periimplat tissue reactions occurred. The obser-
vation of popliteal and inguinal lymph nodes showed no
signs of swelling or morphological alteration due to in-
flammatory or degenerative processes.
3.2.1.1 Microtomographic and dynamic histomorpho-
metric evaluations The VOI selected to perform the mi-
cro-CT measurements according to the three scanning
planes (longitudinal, coronal, and sagittal) and a tridi-
mensional reconstruction of this were reported in Fig. 4.
The statistical analysis onto 3D morphometric results
highlighted a significant (P\ 0.05) difference between SB
and SB- materials for bone volume density (BV/TV) as
showed in Fig. 5. No significant differences were found
between SB and SB- materials for the quantitative eval-
uation of the material volume (Mat.V/TV) and bone tissue
surface (BS/BV) parameters.
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Concerning the quantitative evaluation of Oxytetracy-
cline fluorochrome, the results were reported in Fig. 6.
MAR parameter was statically higher for SB materials
respect to SB- (P\ 0.05), while no significant differences
were detected in BFR values between materials.
3.2.1.2 Qualitative histological evaluation Neither in-
flammation nor adverse tissue reaction were detected
around both granules materials and no immunogenic event
triggered by the presence of bovine collagen occurred. As
expected, 3 months after surgery, the created defects were
completely occupied by newly grown trabecular tissue in
both SB and SB- material. The histological evaluation re-
vealed no qualitative differences between materials,
showing both materials granules almost completely sur-
rounded by bone tissue, which grows tight in contact with
the surface of them without the interposition of fibrotic or
inflammatory tissue. Granules appeared confined in the
previously created surgical defect, but at the same time
well distributed, thus avoiding excessive packing or dis-
persion phenomena (Fig. 7a, b). Cross sectional histologies
showed different size and dimension of granules materials
that appear as ‘‘embedded’’ in bone tissue that grew
forming a bridges between granules of well-structured
trabeculae that displayed a similar morphology that closely
Fig. 1 a ATR-IR spectrum of
SB in the range
500–4000 cm-1; b detail of
triply degenerated asymmetric
stretching mode (m3) of the P–O
bond of the phospate group
Table 1 Surface composition, as detected by XPS, of SB- and SB
granules surface composition (at.%)
Sample O Ca C P N
SB- 45.8 21.9 20.8 11.6
SB 19.3 5.2 61.9 1.7 11.9
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resembles that of host tissue (Fig. 7a, b). As shown in
Fig. 7c, d active areas of deposition were detectable in
close proximity of materials: osteoid was extensively de-
posited along the surface of bone trabeculae and above
them rows of osteoblasts were aligned.
4 Discussion
Biomolecular modification of implant materials is a
promising approach to upgrade properties of conventional
devices. In fact, in the last years it was used to function-
alize biomaterials by using bioactive molecules such as
protein-like collagen, bone morphogenetic proteins, growth
factors and peptides and/or protein domain [28–31]. As
well known, the host response to a biomedical implant
starts with proteins absorption onto materials surface that
trigger and dictate the subsequent biological cascade of
events [32, 33]. Thus the localization at the implant-host
tissue interface of specific signaling molecules can improve
implant biological performance and the host acceptance,
directing simultaneously the healing, regeneration
mechanisms and integration processes.
In this perspective, the surface of calcium phosphate
material was bioactive engineered through its cross-linked
functionalization with collagen type I nanolayer, to create
specific sites of interaction able to elicit osteoblasts and
mesenchymal stem cells recruitment, differentiation and
proliferation. In fact convincing evidence exists that shows
that a surface layer of collagen on titanium fixtures sti-
mulates periimplant bone regeneration [34–44].
Therefore in the present research, a well-defined
biphasic ceramic bone filler, as described in the seminal
work by Daculsi ([45] and references therein), composed of
25 % hydroxylapatite–75 % b-tricalciumphospate, was
further surface engineered with a cross-linked nanolayer of
type I collagen from porcine source (SB). The interaction
of osteoblasts with uncrosslinked collagen I coating on
calcium phosphate ceramic was described by Brodie and
coworkers [46]. In the present case the surface-adsorbed
collagen layer was further crosslinked, to prevent early
disruption of the collagen layer by collagenase in the
wound site (a discussion on the role of cross-linking in the
stability of collagen surface layers has been presented
elsewhere [47]. De Jong and coworkers presented inter-
esting results on osteogenic effect of electrosprayed
nanoscale collagen/calcium phosphate coatings. The de-
position technique adopted by De Jong and coworkers
yields coating thickness of 90 or 120 nm in the quoted
paper. In the present study the process in based on protein
interfacial adsorption and thinner layers are obtained [47].
Several investigations techniques were adopted to con-
firm the surface functionalization: ATR-IR and XPS were
used to characterize the chemical nature of material surface
and the in vitro expression of marker of early osteogenic
activity (ALP) was assessed from no-committed mes-
enchymal cells by RT-PCR.Material histocompatibility was
also evaluated in an in vivo model, adopting microtomo-
graphic, histological and histomorphometric investigations.
The surface localization of the collagen layer is con-
firmed by the results of surface characterization. ATR-IR
analysis failed to detect contribution from organic phases
to the SB spectrum, while XPS clearly detected the turning
of surface chemistry from the inorganic phosphate ceramic
SB- to the organic, proteinaceous environment SB. In
particular, ATR-IR probed a sampling depth slightly below
1 micrometer, but failed to detect the presence of collagen
on the inorganic phosphate ceramic matrix (Fig. 1a). This
is indeed the case for fillers that contain collagen or pro-
teins in their bulk composition, such as natural bone and
the low-temperature treated bovine bone OsteoBiol [48].
Fig. 2 High resolution C1 s peak of SB
Fig. 3 Fold expression of ALP gene by hMSC cultured on SB over
hMSC cultured on SB-. Diamond: osteogenic medium; filled square:
non differentiating medium. Differences are statistically significant
(P[ 0.01) for 7 and 14 days datapoints
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On the other hand, XPS analysis, that samples a depth
about one hundred times thinner, of a few nanometers,
clearly identifies the surface collagen layer (Table 1).
These results should be compared with the interesting
findings presented by Figuereido and coworkers [48]. In
their paper, collagen was detected by ATR-IR of samples
where it is a structural component, such as natural bone and
the low temperature processed Osteobiol xenograft filler. In
Fig. 4 Volume of interest
(VOI) selected to perform the
micro-CT measurements,
according to the three scanning
planes: longitudinal, coronal,
and sagittal respectively of SB
(a) and SB- (b) material.
Tridimensional reconstruction
of the volume of interest (VOI)
selected to perform the
microtomographic
investigations of SB (c) and SB-
(d) materials. The blue color
areas correspond to the
materials, while those in dark
gray correspond to the newly
formed bone tissue (Color figure
online)
Fig. 5 Histograms of 3D morphometric results (BV/TV, %; Mat.V/
TV, %; BS/BV, mm-1) obtained for SB and SB- materials at
3 months (mean ± SD; n = 9 implant sites). Student t test:
*P\ 0.05
Fig. 6 Histograms of mineral apposition rate (MAR, lm/day) and
bone formation rate (BFR, m2/lm/day) obtained for SB and SB-
materials at 3 months (mean ± SD; n = 9 implant sites)
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those cases, collagen is evenly distributed in the inorganic
matrix, while in the present one it is localized at the sur-
face, within a thickness of the order of nanometers. Thus,
the picture that arises from present surface analysis data is
that of phosphate ceramic granules interact with the sur-
rounding tissue by means of a few nanometer coat of
specific collagen type I chemistry.
Results of the evaluation of ALP gene expression con-
firms that the surface nanolayer successfully provides cues
that stimulate progression of hMSC along the osteogenic
pathway [20]. This was verified in further separated ex-
periments evaluating also a panel of osteogenesis-related
genes (data not shown). Current tests performed in non-
differentiating medium, without any contribution from
soluble stimuli, showed statistically significant differences
in ALP expression by hMSC cultured on SB versus SB-.
From a cellular standpoint, here SB provided also
osseoinduction, or the ability to induce differentiation of
pluripotential cells from surrounding tissue to an os-
teoblastic phenotype. The obvious interpretation is that in
both cases the stimuli contained in the culture medium (b-
glycerophosphate, ascorbic acid and dexamethasone)
promoted progression along the osteogenic pathway of
cultured hMSC, over and above any contribution from the
culture substrate [20]. The long term (i.e. 14 days) data
were probably affected by the onset of cellular degradation
in the culture well, and they suggest that the only variable
involved in the experiment (the different surface chem-
istry), can stimulate ALP expression by cultured undiffer-
entiated hMSC. In agreement with reports on the effect of
surface layer of collagen on plastic and titanium [20, 49], it
could be stated that the surface cross-linked collagen on SB
granules offered molecular cues that promoted progression
of hMSC along the osteogenic pathway.
Concerning the in vivo evaluation of histocompatibility,
the current results proved that SB and SB- bone fillers are
both histocompatible and osteoconductive materials as
suggested by the formation of new trabecular bone tissue in
all surgical defects. Nevertheless, statistical analysis high-
lighted that a significant difference exists in the amount of
mineralized bone tissue (BV/TV) between animals treated
with SB compared to those that have received SB- mate-
rials (P\ 0.05). The fluorochrome agent used to quantify
and visualize the velocity and the direction of bone tissue
Fig. 7 Representative histological images obtained from SB (a,
c) and SB- (b, d) materials 3 months after surgery. Stevenel Blue
staining counterstained with Picrofucsin according to Van Gieson was
performed. (scale bar a and b = 100 lm; c and d = 20 lm)
Materials granules of both materials (a, b) were almost completely
surrounded by bone tissue, which grows tight in contact with the
surface of them without the interposition of fibrotic or inflammatory
tissue. Granules materials appeared as ‘‘embedded’’ in bone tissue
that grew forming bridges between granules of well-structured
trabeculae. Active areas of deposition were detectable in close
proximity of both materials (c, d): osteoid was extensively deposited
along the surface of bone trabeculae and above them rows of
osteoblasts were aligned (Color figure online)
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growth, revealed a major degree of mineralization for SB
material (P\ 0.05) in comparison with SB- confirming the
BV/TV results and suggesting a greater and faster os-
teoblast activity around granules material.
Histological evaluation revealed no differences in the
quality of bone between the engineered surface material
(SB) and the control (SB-). A direct apposition of new
bone onto both granular surface materials was detected
without the presence of inflammatory or adverse tissue
reaction eventually evoked by the potential immuno-
genicity of bovine collagen. Bone tissue appears well or-
ganized around both materials granules, which remained
confined to the surgical defect area, with an evenly dis-
tribution. Thus the drawback frequently reported and re-
lated to the excessive packing of granular material was
avoided. In fact, as clearly demonstrate by the histological
images, bone tissue infiltrated both materials taking ad-
vantage by the whole exposed surface.
Several reports in literature, as those published by Sta-
dlinger research group, deeply investigated the effect ex-
erted by material surface coating with organic components
of extracellular matrix onto in vivo osseointegration pro-
cesses [44, 50–52]. In particular, collagen type I, collagen
type III, RGD peptides represent the biological molecules
most commonly employed to increase materials perfor-
mance. Also the present authors investigated and con-
firmed the aforementioned phenomenon in previous
published papers, both in vitro and in vivo [39, 43, 53], but
to the author’s knowledge no data are yet available onto
calcium phosphate synthetic bone fillers engineered with
collagen nanolayer.
5 Conclusions
Based on the present results, it can be argued that engi-
neered surface functionalized with a collagen type I
nanolayer enhance the inherent osteoconductivity proper-
ties of calcium phosphate material as demonstrate by the
histomorphometric results (BV/TV and MAR parameters).
Moreover ALP gene expression by un-differentiated
hMSC gives the successful evidence that osteoinductive
characteristic was conferred to material by the engineered
surface thus overcoming the main disadvantage of calci-
um phosphate. Finally, the present results confirming that
material interaction with the biological environment was
facilitated by the exposure of molecule cues that resem-
bles the surrounding physiological extracellular matrix.
Simultaneously, they provide firmer site of recognition
and adhesion for cells, creating an advantage for the
materials, because uncontrolled non-specific protein ad-
sorption was avoided.
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